The use of recombinant adenovirus (Ad) vectors containing genetically modified capsid proteins is an attractive strategy for achieving targeted gene transfer. The HI loop of the fiber knob is a promising candidate location for the incorporation of foreign ligands for achieving this goal. However, the method of constructing an Ad vector containing a foreign ligand in the HI loop of the fiber knob has proved difficult. In this study, we developed a simple system to construct fibermodified vectors. To do this, a vector plasmid containing a complete E1/E3-deleted Ad type 5 genome and a unique Csp45I and/or ClaI site between positions 32679 and 32680 of the Ad genome (residues threonine-546 and proline-547 of the fiber protein) was constructed. Oligonucleotides corresponding to the Arg-Gly-Asp (RGD) or Asn-Gly-Arg (NGR)-containing peptide motif (as a model) and containing a
Recombinant adenovirus (Ad) vectors are attractive vehicles for in vitro and in vivo gene transfer to a wide variety of cell types. 1, 2 However, one of the limitations in the use of Ad vectors for gene transfer is the nonspecific tissue distribution after in vivo gene transfer and/or the inefficient gene transfer into cells lacking in one of the adenovirus receptors, coxsackievirus and adenovirus receptor (CAR). [3] [4] [5] [6] Ad infection requires two sequential steps. The first involves the attachment of the C-terminal knob domain of the fiber protein to the CAR on the cell surface. 3, 7 Following binding, virus internalization via receptormediated endocytosis takes place through the interaction of the RGD motif of the penton bases with the secondary host cell receptors, ␣ v ␤ 3 and ␣ v ␤ 5 integrin. 8, 9 The viral particle then escapes from the endosome and translocates to the nucleus.
Modification of fiber protein is an attractive strategy for altering the Ad tropism. Two approaches have been used for such modification. The first method is the Csp45I and/or ClaI recognition site, were ligated into the Csp45I and/or ClaI-digested plasmid. The foreign transgene expression cassette was inserted into the E1 deletion site of the vector plasmid and the fiber-mutant Ad vector was produced by transfection of the PacI-digested plasmid into 293 cells. The virus containing the RGD or NGR peptide on the fiber knob was able to infect human glioma cells, which do not express coxsackievirus and adenovirus receptor (CAR), one of the Ad virus receptors, about 100-1000 times more efficient than the virus containing wild-type fiber. This suggested that the mutant virus mediated CAR-independent cell entry pathway. The simplicity of this method allows not only for easy construction of fiber-mutant Ad vectors, but also for screening of the peptides that target the vector to the desired cells and tissues. Gene Therapy (2001) 8, 730-735.
addition of foreign peptides to the C-terminal end of the fiber knob, 10-13 while the second method involves the insertion of foreign peptides into the HI loop of the fiber knob. [14] [15] [16] In both systems, Ad tropism can be expanded by the binding of the foreign ligand to the cellular receptor, although true targeting cannot be obtained, because the native tropism is still maintained. Expanded tropism has been observed by use of mutant fiber proteins containing a stretch of lysine residues 10-13 or a RGD motif, 14, 16 which target to the heparan sulfate or ␣ v integrin on the cellular surface, respectively. Based on several recent reports, the insertion of foreign peptides into the HI loop of the fiber protein appears to be more desirable than the addition of the peptides into the C-terminal portion of the protein, because modification of the C-terminal end sometimes prevents fiber trimerization and virus growth. 17 In addition, the C-terminus of the fiber points toward the virion, 18 and thus is not the optimal site for the addition of foreign ligand. In contrast, insertion of foreign peptides into the HI loop should not affect fiber trimerization 14, 15 and leaves the peptides exposed on the outside of the virion. 15, 19 However, the complexity of inserting foreign DNAs corresponding to the peptide of interest into this region of the fiber gene hampers the development of retargeted vectors. One study used a homologous recombination method in bacteria after the construction of a mutant fiber gene cloned in the plasmid to make such a vector. 14, 15 However, this method required at least five steps, including transformation of the plasmid into different kinds of bacterial strains to produce the fiber-mutant Ad vector.
In this study, we developed a simple system that requires only a two-step, in vitro ligation to construct a fiber-mutant Ad vector containing the gene of interest. Two unique restriction sites, Csp45I and/or ClaI, were introduced into the sequence corresponding to the HI loop of the fiber gene that is cloned in the Ad vector plasmid with an E1/E3-deleted whole Ad genome. Therefore, the oligonucleotides corresponding to the foreign peptide of interest can be inserted into the HI loop of the fiber knob and a transgene containing vector created by this simple method. 20, 21 As a proof-of-principle we demonstrate the creation and characteristics of an Ad vector with an insertion of a RGD peptide in the HI loop of the fiber knob and a luciferase expression cassette into the E1 deletion region. We also report the enhanced gene transfer activity of Ad vector containing the NGR peptide on the fiber knob.
The vector plasmids pAdHM15, -16, -17 and -18 were constructed as described below. pEco-ITR1, 21 which contains the right end of the Ad type 5 genome (from bp 27331 to the right end of the genome (⌬27865-30995)) was cut by ApaI and MunI, and ligated with the ApaI/MunI fragment of pBR-AM2, which is a pBR322-derived plasmid with an AgeI and a MunI site between the AatII and BsaI sites and a deletion between the PvuII and Bst1107I sites. The resulting plasmid, pBR-AM3, contained the Ad genome (31905-32825). Then, four-piece ligation was performed using the ApaI/AseI fragment of pBR-AM3, 
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ApaI/BsmAI fragment of pBR-AM3, BsaAI fragment of pBR-AM3, and oligonucleotide 1 (5Ј-AACAGG AGACACAACTTCGAACATCGATCCAAGTGCATACTC TATGTCATTTTCATGGGACTGGTCTGGCCACAACTA-CAT-3Ј) and 2 (5Ј-TAATGTAGTTGTGGCCAGACCAGT CCCATGAAAATGACATAGAGTATGCACTTGGATCG ATGTTCGAAGTTGTGTCTCC-3Ј; Csp45I or ClaI (Dam methylated) recognition sequences are underlined and italicized, respectively), resulting in pBR-AM4. pEco-AM4 were constructed by ligating the HpaI/MunI fragment of pBR-AM4 and the HpaI/MunI fragment of pEco-ITR5, the latter of which contains the right end of the Ad type 5 genome (from bp 27331 to the right end of the genome (⌬28133-30818)). Finally, pAdHM15 were constructed by the ligation of the SrfI/ClaI fragment of pAdHM2-1, which is a derivative of pAdHM2, 20 and the Srf/ClaI fragment of pEco-AM4, after which the ClaI site at the right end of the Ad genome was changed into a PacI site by using oligonucleotides 3 (5Ј-CGTTAATTAA-3Ј) (PacI recognition sequences are underlined). pAdHM16, -17 and -18 were constructed in the same manner. pAdHM15, -16, -17 and -18 have a complete E1/E3-deleted Ad genome with I-CeuI, SwaI, and PI-SceI sites in the E1 deletion region and a Csp45I and/or ClaI (Dam methylated) site between positions 32679 and 32680 of the Ad genome (residues threonine-546 and proline-547 of the fiber protein) as shown in Figure 1 .
To construct a vector plasmid with a foreign oligonucleotide corresponding to the RGD-4C peptide, CDCGRDCFC, which binds with high affinities to integrins (␣ v ␤ 3 and ␣ v ␤ 5 ) on the cell surface, [22] [23] [24] pAdHM15 was cut by Csp45I/ClaI and ligated with oligonucleotides 4 (5Ј-CGAAGTGTGACTGCCGCGGAGACTGTTTCTG-3Ј) and 5 (5Ј-CGCAGAAACAGTCTCCGCGGCAGTCA-CACTT-3Ј). Next, ligated DNAs were transformed into DH5␣, resulting in pAdHM15-RGD (Figure 2 ). The diagram in Figure 1 illustrates the sequences around the site of insertion of foreign oligonucleotides and the oligonucleotides that can be synthesized for each vector plasmid. Since Csp45I and ClaI produce compatible cohesive ends and the oligonucleotide can be inserted from either orientation, the oligonucleotide was designed so that the positive plasmid has a Csp45I site, but not a ClaI site (Figure 2 ). Both the self-ligated plasmid and the plasmid whose oligonucleotides are oriented in the opposite direction lack a Csp45I site. For this reason, the positive clone can be easily identified. Sequencing of the inserted oligonucleotides in pAdHM15-RGD verified that the clones contained the appropriate sequence.
Next, pAdHM15-RGD-CMVL2 was constructed by an in vitro ligation method 20, 21 using I-CeuI/PI-SceI-digested pAdHM15-RGD and pCMVL1, which contains luciferase gene (derived from pGL3-Control (Promega, Madison, WI, USA)) in pHMCMV6. 21 I-CeuI and PI-SceI are rarecutting enzymes that recognize at least 9, 10 and 11 bp, respectively. 25, 26 As a control virus containing wild-type fiber protein, pAdHM4-CMVL2 was constructed by the ligation of pAdHM4 and pCMVL1. 20, 21 Both pAdHM15-RGD-CMVL2 and pAdHM4-CMVL2 contained the cytomegalovirus (CMV) promoter-driven luciferase gene and the bovine growth hormone (BGH) polyadenylation signal.
To prepare the virus, pAdHM15-RGD-CMVL2 and pAdHM4-CMVL2 were digested with PacI and purified by phenol-chloroform extraction and ethanol precipitation.
Linearized pAdHM15-RGD-CMVL2 and pAdHM4-CMVL2 were transfected into 293 cells. Viruses (AdRGD-L2 and Ad-L2) were prepared as described previously 20 ( Figure 2 ) and purified by CsCl 2 step gradient ultra-centrifugation followed by CsCl 2 linear gradient ultra-centrifugation. Determination of virus particle titer was accomplished spectrophotometrically by the method of Maizel et al. 27 The plaque-forming unit to particle ratio of the virus was 1:23 for AdRGD-L2 and 1:8 for Ad-L2. DNA restriction analysis showed that the vector plasmid with or without the luciferase expression cassette and viral DNA contained the expected fragments (Figure 3) .
Figure 3 Restriction endonuclease analysis. (a) The vector plasmid (pAdHM15-RGD or pAdHM15-RGD-CMVL2) or the luciferase-expressing recombinant adenovirus DNA with the RGD-4C peptide in the fiber knob (AdRGD-L2) was digested with
Dmitriev et al 14 first developed an Ad vector having an RGD-4C peptide, CDCRGDCFC, incorporated into the HI loop of its fiber knob, and demonstrated that this virus was capable of mediating a RGD-integrin-dependent, CAR-independent, gene delivery. The only difference between the fiber contained in our vector (AdRGD-L2) and that contained in their vector is that AdRGD-L2 has three additional amino acids flanking the RGD-4C peptide (RGD-4C, SKCDCRGDCFCD -additional three amino acids are underlined) due to the additional nucleotides contained within the Csp45I and ClaI recognition sites.
To examine the functionality of the RGD-4C peptide in the fiber of AdRGD-L2, SK HEP-1 28 and LN444 cells 29 were transduced with AdRGD-L2 or Ad-L2. Two days later, luciferase expression was determined by a luciferase assay system (PicaGene LT2.0, Toyo Inki Co. Ltd, Gene Therapy Tokyo, Japan) ( Figure 4 ). The RGD-4C peptide binds with high affinities to both ␣ v ␤ 3 and ␣ v ␤ 5 . 24 Therefore, the level of CAR and integrin (␣ v ␤ 3 and ␣ v ␤ 5 ) expression in these cells were also examined by flow cytometry with a Cyto ACE-150 Auto Cell Screener (JASCO, Tokyo, Japan) ( Figure 5 ). The luciferase enzymatic activity following transduction with AdRGD-L2 and Ad-L2 was only four to eight times different in SK HEP-1 cells. In contrast, LN444 cells transduced with AdRGD-L2 and Ad-L2 resulted in approximately a 1000-fold difference in detectable luciferase activity (Figure 4 ). LN444 cells expressed integrins (␣ v ␤ 5 ) but expressed no or only small amounts of CAR, while SK HEP-1 cells expressed both CAR and integrins (␣ v ␤ 5 ) ( Figure 5) . Thus, the presence of the RGD-4C peptide in the fiber knob was required for efficient transduction of these CAR-deficient cells. These results suggested that AdRGD-L2 infected CAR-deficient cells via an RGD integrin-dependent, CAR-independent cell entry pathway in a manner similar to that of the vector developed by Dmitriev et al. 14 We also constructed an Ad vector having an NGR peptide, CNGRCVSGCAGRC, on the fiber knob. Luciferase expressing the Ad vector containing the NGR peptide, AdNGR-L2, was created by the same method as that used for AdRGD-L2 (plaque-forming unit to particle ratio of the virus was 1:30 for AdNGR-L2). Oligonucleotides 6 (5Ј-CGGCTGCAACGGCCGCTGCGTGAGCGGCTGCGC CGGCCGCTG-3Ј) and 7 (5Ј-CGCAGCGGCCGGCGCAGC CGCTCACGCAGCGGCCGTTGCAGC-3Ј) were inserted into the ClaI site of pAdHM15. This peptide sequence was originally isolated as a tumor-forming peptide by a phage display library and recognized different cellular receptors from the RGD-4C peptide. 22 Aminopeptidase N (CD13) has recently been isolated as a molecule recognized by the NGR peptide. 30 We examined the expression levels of CD13 on SK HEP-1 and LN444 cells and the transduction efficiency of AdNGR-L2 (Figures 4 and 5) . As shown in Figure 4 , AdNGR-L2 mediated luciferase expression at levels approximately 100 times higher in CAR-deficient LN444 cells expressing moderate amounts of CD13 than Ad-L2, although the activity was less than that with AdRGD-L2. In contrast, SK HEP-1 cells transduced with AdNGR-L2 and Ad-L2 resulted in similar levels (1.5 to two times difference) of detectable luciferase activity. Thus, AdNGR-L2 infected the cells via both CAR-dependent and CAR-independent (NGR-CD13-dependent) cell entry pathways. This is the first report showing the enhanced gene delivery by the Ad vector containing the NGR peptide on the fiber knob. As the NGR peptide has a higher affinity to tumor vasculature, 22 Ad vector containing the NGR peptide could be useful for anti-angiogenic gene therapy.
Recently, various peptides capable of binding to specific tissues in vivo, such as tumor and brain have been discovered by using phage display libraries. 22, 23, [31] [32] [33] Inclusion of these peptides, which are recovered by the selected phage in the fiber of the Ad vector may direct the vector to desired tissues and cells at higher affinities than a vector containing wild-type fiber. The simplicity of the method described here would allow rapid and easy screening of various Ad vectors with peptide ligands for targeted delivery, although the vectors containing foreign peptide in the HI loop of the fiber knob still have the binding activity with its native receptor, CAR.
We constructed various vector plasmids (pAdHM15, -16, -17 and -18; Figure 1a ) that contain different sequences at the Csp45I and/or ClaI recognition sites to vary the additional few amino acids that are included when cloning in new fiber peptides. For example, pAdHM16 has Ile (I) and Asp (D) as shown in Figure 1b . The viruses derived from pAdHM16, -17 and -18 have only two additional amino acids. In the case of screening a large number of foreign peptides, it is desirable that the method for producing fiber-mutant Ad vectors be as simple as possible. If the gene of interest to be inserted into the E1 deletion region does not have a Csp45I and/or ClaI site and the vector plasmid containing gene of interest is used, various Ad plasmids containing both foreign peptides in the fiber and gene of interest can be prepared in a one-step ligation reaction. The vector plasmid containing the gene of interest is cut by Csp45I and/or ClaI, after which oligonucleotides are introduced into the fiber-coding region. In this way, various fiber-mutant Ad vectors containing the gene of interest can be produced with minimal labor.
Recently, systems for the propagation of Ad vectors with genetically modified receptor specificities were reported. [34] [35] [36] In these systems, packaging cell lines expressing pseudoreceptors were developed to produce the targeted Ad vector with a pseudoligand. The system described here, combined with such packaging cell lines containing new ligands for vector binding in the absence of CAR, 36, 37 should be a powerful tool for the construction of targeted recombinant Ad vectors for gene therapy.
